| scholarly article | Q13442814 |
| P50 | author | Marylyn Addo | Q66714025 |
| P2093 | author name string | Daniel E Kaufmann | |
| Philip J Norris | |||
| Eric S Rosenberg | |||
| Otto O Yang | |||
| Howell F Moffett | |||
| Margaret J Clark | |||
| P2860 | cites work | The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry | Q24315492 |
| Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection | Q24645815 | ||
| Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 | ||
| Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
| Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells | Q28270680 | ||
| The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 | Q29616093 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay | Q29619255 | ||
| Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection | Q30465682 | ||
| Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection | Q33817504 | ||
| CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection | Q33834466 | ||
| Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection | Q33869806 | ||
| High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation | Q33950164 | ||
| HIV preferentially infects HIV-specific CD4+ T cells | Q33958893 | ||
| Cellular immune responses to HIV. | Q34223069 | ||
| HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses | Q34389601 | ||
| Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. | Q34468117 | ||
| CD4(+) T helper cells and the role they play in viral control | Q34732241 | ||
| Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. | Q35867686 | ||
| Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms | Q35881271 | ||
| Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo | Q36375248 | ||
| HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women | Q36376747 | ||
| Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele | Q36380434 | ||
| Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells | Q36909497 | ||
| Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. | Q36943282 | ||
| Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency | Q37365738 | ||
| Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones | Q39604412 | ||
| A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6 | Q40049315 | ||
| Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion | Q42818707 | ||
| HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression | Q43750477 | ||
| Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo | Q44501224 | ||
| Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection | Q44519261 | ||
| Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors | Q45741753 | ||
| Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells | Q45788355 | ||
| Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus | Q45878763 | ||
| Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes | Q46161496 | ||
| Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor | Q46550585 | ||
| Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. | Q51601146 | ||
| A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis | Q57080563 | ||
| Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones | Q58991727 | ||
| Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture | Q59097936 | ||
| Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine | Q68515337 | ||
| Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice | Q70723869 | ||
| Characterization of CD4(+) CTLs ex vivo | Q74145676 | ||
| Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates | Q77580234 | ||
| Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection | Q79330614 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8844-8851 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells | |
| P478 | volume | 78 |
| Q36880380 | A novel SIV gag-specific CD4(+)T-cell clone suppresses SIVmac239 replication in CD4(+)T cells revealing the interplay between antiviral effector cells and their infected targets |
| Q92636833 | Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller |
| Q34480617 | Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development |
| Q39124318 | Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection. |
| Q36600351 | Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development |
| Q41190952 | Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts in HIV-infected Mexican mestizos |
| Q56772813 | Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine |
| Q34841938 | CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis |
| Q34234563 | CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination |
| Q27477717 | CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System |
| Q46087050 | CD8 T cell effector maturation in HIV-1-infected children |
| Q30353071 | Cell-mediated protection in influenza infection. |
| Q41916926 | Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages |
| Q33721009 | Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques |
| Q37812127 | Cytolytic CD4+T cells in viral immunity |
| Q37597931 | Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection? |
| Q21296742 | Cytotoxic CD4 T cells in antiviral immunity |
| Q36286343 | Cytotoxic effector functions of T cells are not required for protective immunity against fatal Rickettsia typhi infection in a murine model of infection: Role of TH1 and TH17 cytokines in protection and pathology |
| Q35224581 | Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity |
| Q35484743 | Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques |
| Q27003380 | Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model |
| Q56994404 | Elite control of HIV infection: implications for vaccine design |
| Q37615584 | Factors Associated with the Size of HIV DNA Reservoir |
| Q40086525 | Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection. |
| Q37667998 | Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells |
| Q37206430 | Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection |
| Q39026150 | HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer+ Gag-Specific CD4+ T Cells in Chronic Clade C HIV-1 Infection |
| Q95847922 | HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo |
| Q35665966 | HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome |
| Q41937295 | HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome |
| Q35753766 | HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses. |
| Q37051248 | HLA/KIR restraint of HIV: surviving the fittest |
| Q34033051 | Immunity to HIV in Early Life |
| Q36360161 | Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques. |
| Q42130441 | Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease |
| Q52719601 | Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease. |
| Q38086432 | Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses |
| Q64074435 | Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques |
| Q41992035 | Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection |
| Q35947812 | Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells |
| Q37020616 | Networking at the level of host immunity: immune cell interactions during persistent viral infections |
| Q37255619 | Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice |
| Q49124572 | Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine. |
| Q92702651 | Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype |
| Q47551145 | Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis |
| Q50281273 | Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine. |
| Q39938289 | Protein kinase C theta regulates stability of the peripheral adhesion ring junction and contributes to the sensitivity of target cell lysis by CTL. |
| Q43096910 | Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages |
| Q36580911 | The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. |
| Q36060423 | The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope |
| Q54253587 | The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques. |
| Q40302787 | The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells |
Search more.